SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

X4 Pharmaceuticals, Inc (XFOR)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Sep. 15, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Sep. 15, 2025 CORRESP Neutral/Informational Moderate X4 Pharmaceuticals, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-3. They are seeking to have it declared effec… Read Filing EDGAR
Sep. 15, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated September 15, 2025, informs Adam Craig, Executive Chairman of X4 Pharmaceuticals, Inc., that the SEC has not reviewed and will not review the company'… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.